Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cadazolid vs Vancomycin in CDAD (IMPACT 1)
NCT01987895Phase 3Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Mar 2014
- Primary completion
- Feb 2017
- Modality
- Bivalent/Multivalent Binders, Orthosteric Ligands, RNA-Targeting Small Molecules
01
Overview
A Phase 3 trial of cadazolid in Clostridium difficile infection (CDI), sponsored by Actelion Pharmaceuticals Ltd. Started Mar 2014; status: completed.
02
Drugs
cadazolid
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT01987895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01987895.